POSITION STATEMENT

Turkish IBD Organization’s Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemic

Volume 32 · Issue 6 Publish Date: June 15, 2021
Murat Törüner İsmail Hakkı Kalkan Filiz Akyüz Ahmet Tezel Aykut Ferhat Çelik
Full Text PDF
DOI

Published In

Turkish Journal of Gastroenterology

Volume 32 · Issue 6

Pages: 488-492

History

Published Online: June 15, 2021

Copyright © 2021 Murat Törüner, İsmail Hakkı Kalkan, Filiz Akyüz, Ahmet Tezel, Aykut Ferhat Çelik

Murat Törüner
Department of Gastroenterology, Ankara University School of Medicine, Ankara, Turkey
İsmail Hakkı Kalkan
Department of Gastroenterology, Türkiye Yüksek ihtisas Training and Research Hospital, Ankara
Filiz Akyüz
Covering the Cover Editor
Ahmet Tezel
Department of Gastroenterology, Trakya University School of Medicine, Edirne, Turkey
Aykut Ferhat Çelik
Department of Gastroenterology, İstanbul University, Cerrahpaşa School of Medicine, İstanbul
Törüner, M., Kalkan, İsmail H., Akyüz, F., Tezel, A., & Çelik, A. F. (2021). Turkish IBD Organization’s Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemic. Turkish Journal of Gastroenterology, 32(6), 488–492. https://doi.org/10.5152/tjg.2021.280721
Endnote/Zotero/Mendeley (RIS) BibTeX
Full Text Full Text PDF

Abstract

The COVID-19 pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2, has resulted in high mortality and morbidity worldwide and is still a growing problem. Inflammatory bowel disease (IBD) is a chronic inflammatory disease for which a substantial number of patients are treated with immunosuppressive medications, either occasionally or long-term. Despite the accumulating evidence, there is still a lack of knowledge about the impact of COVID-19 on IBD patients, especially those who are under immunosuppressive treatment. Moreover, following the emergence of several COVID vaccines, there are concerns regarding vaccine effectiveness and possible side effects in such patients. In this context, we tried to briefly summarize the accumulating evidence and recommendations for the management of IBD in the context of the COVID-19 pandemic.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 11 > >> 
Article Info
Published In
Journal Turkish Journal of Gastroenterology
Volume / Issue Volume 32 · Issue 6
Pages 488-492
DOI 10.5152/tjg.2021.280721
History
Published Online June 15, 2021
Copyright
Copyright (c) 2021 Murat Törüner, İsmail Hakkı Kalkan, Filiz Akyüz, Ahmet Tezel, Aykut Ferhat Çelik
Affiliations
Murat Törüner
Department of Gastroenterology, Ankara University School of Medicine, Ankara, Turkey
İsmail Hakkı Kalkan
Department of Gastroenterology, Türkiye Yüksek ihtisas Training and Research Hospital, Ankara
Filiz Akyüz
Covering the Cover Editor
Ahmet Tezel
Department of Gastroenterology, Trakya University School of Medicine, Edirne, Turkey
Aykut Ferhat Çelik
Department of Gastroenterology, İstanbul University, Cerrahpaşa School of Medicine, İstanbul
Cite this Article
Törüner, M., Kalkan, İsmail H., Akyüz, F., Tezel, A., & Çelik, A. F. (2021). Turkish IBD Organization’s Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemic. Turkish Journal of Gastroenterology, 32(6), 488–492. https://doi.org/10.5152/tjg.2021.280721
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX
Outlines